Component
Rat anterior-pituitary growth-hormone release
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
EGTA blocked thymulin-stimulated GH release in dispersed rat pituitary preparations; cAMP enhancers potentiated the response.
Experimental context and source evidence
- evidence_access
- Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
- experimental_condition
- Thymulin without EGTA hormone exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Thymulin without EGTA chelation · EGTA Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "EGTA plus thymulin", "comparator": "Thymulin without EGTA", "endpoint": "EGTA blocked thymulin-stimulated GH release in dispersed rat pituitary preparations; cAMP enhancers potentiated the response.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "egta", "state": "chelation"}, {"entity_slug": "thymulin", "state": "hormone exposure"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat pituitary preparations; extracellular calcium chelation supports calcium-sensitive signaling, not direct calcium binding to thymulin.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- EGTA blocked thymulin-stimulated GH release in dispersed rat pituitary preparations; cAMP enhancers potentiated the response.
- primary_references
- Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent. | 1999 | DOI 10.1159/000054399 | PMID 9892847 | https://pubmed.ncbi.nlm.nih.gov/9892847/
- source_locator
- Reviewed reference lines 106-106; exact primary location described in quoted passage where extracted.
Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 106–106
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat pituitary preparations; extracellular calcium chelation supports calcium-sensitive signaling, not direct calcium binding to thymulin. · Recorded from source · Recorded from source
In a different dispersed-rat-pituitary study using higher concentrations, thymulin stimulated **GH** release; responses depended on age and concentration. EGTA blocked activity, and cAMP enhancers potentiated it. These interventions support calcium-sensitive signaling, not a requirement for calcium bound directly to thymulin. The earlier GH null remains part of the evidence. [1999 GH study](https://pubmed.ncbi.nlm.nih.gov/9892847/)
Complete structured claim and evidenceGH did not increase in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.
Experimental context and source evidence
- evidence_access
- Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
- experimental_contrast
- {"intervention": "Picomolar zinc-thymulin", "comparator": "Matched tissue control", "endpoint": "GH did not increase in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.", "effect_direction": "no_detected_change", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- GH did not increase in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.
- primary_references
- Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. | 1997 | DOI 10.1159/000097322 | PMID 9483196 | https://pubmed.ncbi.nlm.nih.gov/9483196/
- source_locator
- Reviewed reference lines 104-104; exact primary location described in quoted passage where extracted.
Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 104–104
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement. · Recorded from source · Recorded from source
In isolated rat anterior pituitary tissue, picomolar zinc–thymulin stimulated ACTH, accompanied by cAMP changes and cGMP changes at higher tested concentrations. A cAMP-directed phosphodiesterase inhibitor enhanced some responses, whereas the cGMP-directed inhibitor attenuated responses at higher concentrations. LH increased at selected concentrations, **GH did not**, and prolactin decreased. This does not establish human cortisol elevation or blood–brain barrier passage. [1997 study](https://pubmed.ncbi.nlm.nih.gov/9483196/)
Complete structured claim and evidenceHigher-concentration thymulin stimulated GH release in dispersed rat pituitary preparations; responses depended on age and concentration.
Experimental context and source evidence
- evidence_access
- Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
- experimental_contrast
- {"intervention": "Thymulin", "comparator": "Matched cell preparation", "endpoint": "Higher-concentration thymulin stimulated GH release in dispersed rat pituitary preparations; responses depended on age and concentration.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Dispersed rat pituitary cells; higher concentration than earlier tissue study; no universal GH sign.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- Higher-concentration thymulin stimulated GH release in dispersed rat pituitary preparations; responses depended on age and concentration.
- primary_references
- Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent. | 1999 | DOI 10.1159/000054399 | PMID 9892847 | https://pubmed.ncbi.nlm.nih.gov/9892847/
- source_locator
- Reviewed reference lines 106-106; exact primary location described in quoted passage where extracted.
Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 106–106
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Dispersed rat pituitary cells; higher concentration than earlier tissue study; no universal GH sign. · Recorded from source · Recorded from source
In a different dispersed-rat-pituitary study using higher concentrations, thymulin stimulated **GH** release; responses depended on age and concentration. EGTA blocked activity, and cAMP enhancers potentiated it. These interventions support calcium-sensitive signaling, not a requirement for calcium bound directly to thymulin. The earlier GH null remains part of the evidence. [1999 GH study](https://pubmed.ncbi.nlm.nih.gov/9892847/)
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.